Concepedia

K. Mast

KM

3

Publications

183

Citations

3

H-Index

2001

Active since

Affiliations

Abbott Fund(Current)

K. Mast is an author at Abbott Fund specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

MedicinePharmacologyPharmacotherapyHealthHematologyImmunologyPhysiologyThrombosisBiochemistryInflammation

Publications per year

2001–2017

3

Publications

3

First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis

Reheman Adili, Benjamin E. Tourdot, K. Mast et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 105 citations · Full text

Discovery of selective hydroxamic acid inhibitors of tumor necrosis factor-α converting enzyme

James H. Holms, K. Mast, Patrick A. Marcotte et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 52 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +11

In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombi

Reheman Adili, Ellen Voigt, Jordan L. Bormann et al. · Platelets · 2017 · 26 citations · Full text

Docosahexaenoic Acid, Immunology, Pharmacotherapy +22

Rows per page

1–3 of 3